Meet Our Medical Team

Dr. Alvarez is a graduate of the Medical Scientist Training program at the University of Colorado Denver and completed his neurology residency and neuroimmunology fellowship at Washington University in St. Louis. He brings varied experience in MS and other neurological disorders to the Rocky Mountain MS Center at University of Colorado. He has a special interest in using biomarkers to customize treatments and patient care. He moved to the Denver area with his wife and two children. Most of his free time is spent with his family and his golden retriever, Daisy.
Dr. Alvarez’s research interests and projects include retrospective chart reviews, examining how patients have done in clinic outside of clinical trials to better understand how patients have done with their various treatments. He is also expanding the biorepository of cerebrospinal fluid and blood markers in order undertake biomarker studies. These biomarkers, which can also include MRI measures, will hopefully allow us to decide on the right treatment for each patient that will maximize their health with minimal risk.
Dr. Alvarez also provides regular MS specialty care to patients at Denver Health.

Dr. Bennett received his Biochemistry and Philosophy Degrees at Case Western Reserve University. He then received his medical and doctoral degrees at Stanford University. Dr. Bennett directs research programs on optic neuritis, demyelinating disorders, and ocular inflammatory diseases. He also maintains active specialty practices in neuro-ophthalmology, multiple sclerosis, neuromyelitis optica, and neuroimmunology.
As a clinician-scientist, Dr. Bennett is devoted to understanding the effects of autoimmune demyelination on the nervous system and using this knowledge to transform the care of affected individuals. In the clinic, Dr. Bennett directs clinical trials on new therapies for optic neuritis and neuromyelitis optica. In the laboratory, Dr. Bennett is working to identify the targets of the immune response in neuromyelitis optica and multiple sclerosis and is working to understand the mechanisms by which these disorders cause damage to the nervous system. His laboratory uses multiple experimental methods to evaluate the targets and action of antibodies derived from immune cells in the spinal fluid of neuromyelitis optica and multiple sclerosis patients, and employs state-of-the art techniques to establish the role of these antibodies in causing disease. Through his work, he has developed a novel antigen-specific therapy for neuromyelitis optica and is working towards similar goals in multiple sclerosis.

Dr. Robert Gross attended college at Columbia University and medical school at NYU School of Medicine. He completed Internship in Internal Medicine and Residency in Adult Neurology at Brown University in Providence. He then returned to New York to complete a fellowship in Multiple Sclerosis/Neuroimmunology at the CGD Center for MS at Mount Sinai Hospital. Dr. Gross sees patients with MS and related disorders of the central nervous system. He divides his time between patient care, teaching, and clinical research. Research interests include the identification of biomarkers associated with treatment response in MS and the establishment of prospective databases to aid in prognostication. He recently moved to Colorado with his wife and beagle/terrier puppy and is thrilled to be living out West for the first time.

Dr. Kammeyer completed medical school at the Indiana University School of Medicine, and has worked as a child neurology resident until 2019 at Children’s Hospital Colorado at the University of Colorado. He has been involved in the CATCH community health program and in the Global Neurology program at CHCO. He is excited to focus on multiple sclerosis and other neuroimmune diseases over the next year, and to potentially get a haircut. His wife, his son, and he enjoy traveling and hiking new parts of Colorado, and building new play areas that their son rarely chooses to use.

Rachel migrated to the US in 1999, to pursue a masters in information system. However, she wasn’t much of a computer person and decided to go into the health field. She attended University of Colorado Denver for four years, contemplating her major. Her goal was to go to med school, but due to life changes, ended up pursuing nursing. Rachel graduated from University of Colorado School of Nursing in 2014 with her BSN, and joined UCHealth Neurology clinic in January of 2018. When she's not working, she spends time with her son, sister and family, and enjoys music, dancing and travelling.

Dr. Piquet is a graduate of Penn State University School of Medicine and completed her neurology residency at Harvard’s Neurology Program at Massachusetts General Hospital and Brigham and Women’s Hospital. She completed a Neuroimmunology/Autoimmune Neurology Fellowship at the University of Utah. Dr. Piquet sees patients with autoimmune neurological diseases, multiple sclerosis and other inflammatory diseases of the central nervous system. Her main clinical interest includes antibody-mediated disorders of the nervous system such as autoimmune encephalitis and stiff-person syndrome as well as demyelinating disease including multiple sclerosis and neuromyelitis optica spectrum disorder (NMOSD). She has additional expertise in other inflammatory diseases including neurosarcoidosis, vasculitis, and central nervous system complications of rheumatological diseases such as lupus and Sjögren syndrome, among others.

Dr. Piquet’s research interests include optimizing diagnosis and treatment for patients with autoimmune neurological diseases; this includes the development of standardized guidelines and protocols for the diagnostic work up and treatment for autoimmune encephalitis. She is also interested in the identification of biomarkers associated with autoimmune neurological disease.

Dr. Piquet is the Director of the Autoimmune Neurology Program at the University of Colorado, and an Associate Professor of Neurology in the Neuroimmunology, Neuroinfectious Disease and Neurohospitalist Sections.

Dr. Schreiner has a masters degree in public health from Yale University and earned her medical degree from the University of Rochester in Rochester, N.Y. after working in healthcare consulting. Dr. Schreiner completed residency in Pediatric Neurology at the University of Colorado and Children’s Hospital Colorado. She currently sees pediatric neurology patients at Children’s Hospital Colorado, and sees both adults and children with neuroimmunologic disorders at the Rocky Mountain MS Center at University of Colorado. She is a past recipient of the National MS Society Clinical Fellowship Award.

Dr. Schreiner’s research interests include treatment and outcomes of pediatric onset multiple sclerosis. She is particularly interested in cognitive and psychosocial impact of pediatric diagnosis and environmental triggers of disease. She participates in many clinical trials of disease modifying therapies for MS, both adult and pediatric. She directs the Neuroimmunology Clinic for Children, a multidisciplinary clinic for the care of children and adolescents with MS. This clinic is staffed by a neuropsychologist, a psychologist, a social worker, Dr. Schreiner, a research coordinator and a pediatric neurology nurse.”

Dr. Anna Shah was born and raised in Chicago, Illinois. She attended the University of Missouri - Kansas City for both undergrad and medical school. She went on to complete Neurology residency at the University of Michigan, where she served as chief resident in her final year. She completed her fellowship in multiple sclerosis and neuroimmunology at the University of Colorado and has decided to stay on as a clinical attending. She sees patients with Multiple Sclerosis and other related disorders of the nervous system.

Dr. Wolf attended medical school at the University of Colorado Denver School of Medicine, and completed Residency and Fellowships at the University of Colorado. His research interests are focused on improving the treatment of patients with multiple sclerosis and other inflammatory diseases of the central nervous system. Current projects include developing digital and blood biomarkers to detect worsening in multiple sclerosis patients, characterizing clinical outcomes of neuroinvasive West Nile virus infection in patients on anti-CD20 treatments, and understanding the risks of immune checkpoint inhibitor use in patients with neuroimmunological disease. I am also interested in the acute management of demyelinating diseases and optimizing inpatient to outpatient care transitions.